Levim has embarked on finding solutions for unmet disease areas in oncology through innovation with its in-house expertise in the area of gene therapy & drug delivery. We have been successful in materializing our concept to a working molecule and see encouraging results in overcoming resistant cancers, that has a potential for wide range of applications. More lab & preclinical studies are warranted and Levim is on the path to establish necessary scientific data to further validate this technology platform.
